Response to Vaccines in Patients with Immune-Mediated Inflammatory Diseases: A Narrative Review
Review
[키워드] activating
acute respiratory syndrome
Affect
antibody
appear
attenuate
B-cell
biologic
Biologic therapy
coronavirus
CTLA-4
described
dose
Efficacy
evaluated
fusion protein
healthy individuals
IL-17
IL-6
immune response
immune system
Immune-mediated inflammatory disease
Immune-mediated inflammatory diseases
immunosuppressants
immunosuppressive
immunosuppressive drugs
impair
increased risk
Infection
Inflammatory bowel disease
inhibitor
inhibitors
integrin
Interleukins
knowledge
limit
Live attenuated vaccine
narrative
Necrosis
pathogenic
Patient
patients
patients receiving treatment
patients treated
protective immune response
protective response
recommendation
reduced
replicate
response
responses
review
rheumatoid arthritis
risk of infection
Safe
SARS-CoV-2
SARS-CoV-2 vaccination
SARS-CoV-2 vaccine
severe disease
Therapies
therapy
TNF
treat
Treatment
vaccination
Vaccine
vaccine response
Vaccines
[DOI] 10.3390/vaccines10020297 PMC 바로가기 [Article Type] Review
[DOI] 10.3390/vaccines10020297 PMC 바로가기 [Article Type] Review